Dantas GPF, Ferraz FS, Andrade LM, Costa GMJ
Proactive Side-Effect Management: If you experience any gastrointestinal changes or metabolic shifts, we address them immediately
GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
Contact us today to schedule your consultation and see how we can help you build a stronger, leaner body the right way
In this Ask Me Anything (AMA) episode, Peter dives back into the increasingly popular topic of GLP-1 agonists, such as Ozempic and Mounjaro, which have garnered widespread attention for their ability to promote weight loss
Sermorelin: the shortest fully active GHRH fragment Sermorelin takes the opposite design route